SCHEMBL31269077

SCHEMBL31269077

Cc1ccnc(Cn2c(-c3ccc(NS(C)(=O)=O)cc3Cl)nc3c(OC4(C)CC4)ncnc32)c1

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HAVCR2 Q8TDQ0 3/20 0.33
▸ PIK3CD O00329 3/20 0.33
▸ CYP17A1 P05093 3/20 0.33
▸ GAA P10253 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ SCN9A Q15858 2/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ SCN5A Q14524 1/20 0.32
▸ CNR1 P21554 2/20 0.31
▸ CNR2 P34972 2/20 0.31
▸ KIT P10721 2/20 0.31
▸ SCN8A Q9UQD0 1/20 0.31
▸ ADRA1D P25100 1/20 0.31
▸ ADRA1A P35348 1/20 0.31
▸ SLC2A2 P11168 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31269244 0.88 KMT2A (0.34) PIK3CDSCN9AKCNH2SCN5ASCN8A
SCHEMBL31269047 0.88 PIK3CD (0.36) PIK3CDSCN9AKCNH2SCN5ACNR1
SCHEMBL31269106 0.87 INSR (0.32) PIK3CDSCN9AKCNH2SCN5ACNR1
SCHEMBL31269266 0.86 PIK3CD (0.35) PIK3CDSCN9AKCNH2SCN5ACNR1
SCHEMBL31269032 0.86 PARG (0.37) PIK3CDSCN9AKCNH2SCN5ACNR1
SCHEMBL31268908 0.86 KCNJ5 (0.33) PIK3CDCNR1CNR2
SCHEMBL31268984 0.86 PIK3CD (0.33) PIK3CDSCN9AKCNH2SCN5ASCN8A
SCHEMBL31268946 0.86 PIK3CD (0.34) PIK3CDSCN9AKCNH2SCN5A
SCHEMBL31269202 0.85 POLB (0.31) PIK3CDSCN9AKCNH2SCN5A
SCHEMBL30983829 0.85 KCNH2 (0.34) PIK3CDSCN9AKCNH2SCN5ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
Send feedback